What is the Return on Assets (ROA) of Nkarta this year?
The Return on Assets (ROA) of Nkarta is -0.31 undefined this year.
Nkarta ROA 2024
Nkarta ROA
-0.31
Ticker
NKTX
ISIN
US65487U1088
WKN
A2P797
In 2024, Nkarta's return on assets (ROA) was -0.31, a 28.83% increase from the -0.24 ROA in the previous year.
Nkarta Aktienanalyse
What does Nkarta do?
Nkarta Inc is a biopharmaceutical company based in South San Francisco, California. The company was founded in 2015 by Dr. Raphael Rousseau (CEO) to develop a groundbreaking new therapy for cancer patients. The business model of Nkarta is based on the development of novel CAR-T cell therapies. These are a special type of immunotherapy in which the patient's own immune cells are genetically modified and used to target tumor cells. Unlike conventional chemotherapy or radiation, which can also attack healthy cells, CAR-T cell therapies specifically target cancer cells while sparing the surrounding healthy tissue. Nkarta is divided into various business areas, including research and development of new therapies, manufacturing and production of CAR-T cells, and clinical trials and approval processes for broad application. One of Nkarta's key products is NKR-2, a CAR-T cell therapy based on natural killer cells. These cells have high activity against cancer cells and can respond quickly to threats. NKR-2 differentiates itself from other therapies by its ability to be effective even at low concentrations. This means that fewer cells are needed and the risk of unwanted side effects is reduced. Nkarta is also working on other projects, including NKX101, which specializes in treating solid tumors, and Voretigene Neparvovec, a gene therapy for the rare hereditary retinal disease. In 2020, Nkarta entered into a partnership with CRISPR Therapeutics to explore the joint potential of CRISPR gene editing and CAR-T cell therapy. The collaboration aims to improve the precision and effectiveness of CAR-T cell therapies and ultimately increase the chances of a cure for cancer patients. Overall, Nkarta has had an impressive success story in recent years. The company has raised several million dollars in funding and continues to expand. The groundbreaking technology of CAR-T cell therapies is promising and has the potential to have a sustainable impact on healthcare. With Nkarta at the forefront, the future could look much more hopeful for cancer patients. Nkarta ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Nkarta's Return on Assets (ROA)
Nkarta's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Nkarta's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Nkarta's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Nkarta’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Nkarta stock
What was the ROA of Nkarta compared to the previous year?
The ROA of Nkarta has increased by 28.83% compared to the previous year.
What consequences do high ROA have for investors of Nkarta?
A high ROA is advantageous for investors of Nkarta, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Nkarta?
A low ROA can be unfavorable for investors of Nkarta as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Nkarta affect the company?
An increase in ROA of Nkarta can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Nkarta impact the company?
A reduction in the ROA of Nkarta can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Nkarta?
Some factors that can influence the ROA of Nkarta include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Nkarta important for investors?
The ROA of Nkarta is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Nkarta take to improve ROA?
To improve ROA, Nkarta can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Nkarta pay?
Over the past 12 months, Nkarta paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nkarta is expected to pay a dividend of 0 USD.
What is the dividend yield of Nkarta?
The current dividend yield of Nkarta is .
When does Nkarta pay dividends?
Nkarta pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Nkarta?
Nkarta paid dividends every year for the past 0 years.
What is the dividend of Nkarta?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Nkarta located?
Nkarta is assigned to the 'Health' sector.
Wann musste ich die Aktien von Nkarta kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Nkarta from 12/5/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/5/2024.
When did Nkarta pay the last dividend?
The last dividend was paid out on 12/5/2024.
What was the dividend of Nkarta in the year 2023?
In the year 2023, Nkarta distributed 0 USD as dividends.
In which currency does Nkarta pay out the dividend?
The dividends of Nkarta are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Nkarta
Our stock analysis for Nkarta Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nkarta Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
